InfuSystem Holdings, Inc. (AMEX: INFU) is a Healthcare company (Medical - Devices) with a market capitalization of $296M. The Maz Rating grades it against the other companies in its sector.
InfuSystem Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $14.79, InfuSystem Holdings, Inc. trades at 31.6x trailing earnings, 2.1x sales and 4.6x book value, with an EV/EBITDA of 11.8. Over the last twelve months it generated about $144M of revenue and $9M of net income. It runs a gross margin of 57.6%, an operating margin of 9.8% and a net margin of 6.5%. It shows return on equity of 15.8%, return on invested capital of 11.6% and a free cash flow yield of 4.5%. On the balance sheet: a debt-to-equity ratio of 0.35 and a current ratio of 2.68. Over the past 52 weeks the share price ranged from $7.29 to $15.47, with a beta of 1.38.
InfuSystem Holdings, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 4 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, InfuSystem Holdings, Inc. (INFU) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 7.44% / 30% · (Cash+Inv) / Mkt Cap (36m) 3.78% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 7.44% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.44% / 33% · Receivables / Mkt Cap (36m) 11.2% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 7.44% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.44% / 33.33% · Receivables / Mkt Cap (24m) 11.2% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 15.7% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 3.83% / 33.33% · Receivables / Avg Assets (4Q) 25.8% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 18.8% / 33.33% · (Cash+ST Inv) / Total Assets 8.71% / 33.33% · (Cash+Recv) / Total Assets 37.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, InfuSystem Holdings, Inc. (INFU) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
Yes. InfuSystem Holdings, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
InfuSystem Holdings, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.